SREBF1 Polymorphism and Egg Yolk on Cardiovascular Disease Risk in Healthy Young Adults: a Randomised, Two-period, Single Blinded, Crossover Trial
NCT04975048 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2025-05-15
Summary
Our previous analysis showed that sterol regulatory element binding protein gene (SREBF1) rs2236513/rs2297508/rs4925119 polymorphism modulated the relation between dietary cholesterol and serum low density lipoprotein cholesterol /serum total cholesterol. This study aims to confirm and extend this finding by characterizing the effects of cholesterol from egg yolks on lipid profiles in healthy young adults with different SREBF1 genetic makeup. 32 SREBF1 C/G/G minor allele carriers at rs2236513/rs2297508/rs4925119 and 32 SREBF1 AA/CC/AA major homozygotes at rs2236513/rs2297508/rs4925119 were enrolled to test their response to egg yolks.
Conditions
- Healthy
- GEN1 Gene Mutation
Interventions
- DIETARY_SUPPLEMENT
-
Egg yolks
Two egg yolks/day was designed for the study. However, uneven egg sizes during period 1 made the intervention unable to achieve the protocol's recommended cholesterol intake level, and the intervention was modified in period 2 to be 0.8 g egg yolk/day/kg body weight. This dosage was calculated by dividing the 35 g egg yolk with the lightest weight among the volunteers, which was 45 kg. This provides a more consistent cholesterol intake between persons as the egg yolk dosage is standardized for persons with different weights.
- DIETARY_SUPPLEMENT
-
Macronutrients equivalent control
The macronutrients equivalent control group was served 42 g egg white cooked with 10 g olive oil, designed to best imitate the energy and macronutrients of 35 g egg yolk (energy 119 kcal, protein 5 g, fat 10 g, carbohydrate 1 g) since the average weight of two large egg yolk was presumed to be 35 g. As an egg yolk dose of 0.8 g egg yolk per kg body weight per day was served during the intervention period 2, the macronutrients equivalent control was likewise adjusted as follow: subjects who weighed less than 55 kg were served 51 g egg white cooked with 12 g olive oil, which is equivalent to 40 g egg yolk; those who weighed from 55 kg to 65 kg were served 61 g egg white cooked with 14 g olive oil, which is equivalent to 48 g egg yolk; and those who weighed more than 65 kg were served 71 g egg white cooked with 17 g olive oil, which is equivalent to 56 g egg yolk.
Sponsors & Collaborators
-
Chinese Nutrition Society
collaborator UNKNOWN -
Fudan University
collaborator OTHER -
Shandong University
lead OTHER
Principal Investigators
-
Shixiu Zhang, Ph. D. · Shandong University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-14
- Primary Completion
- 2020-01-12
- Completion
- 2025-12-01
Countries
- China
Study Locations
More Related Trials
-
Investigating Age-dependent Effects of Egg Intake on HDL and Immune Profiles
NCT06086795 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With Hypertriglyceridemia
NCT02924558 ·Status: COMPLETED ·Phase: NA
-
Daily Inclusion of Eggs in a Heart-Healthful Dietary Pattern in Hyperlipidemic Adults
NCT05807334 ·Status: UNKNOWN ·Phase: NA
-
Plasma and Urine TMAO Formation and Changes to Oxidized LDL After Ingestion of Different Amounts of Egg
NCT01906554 ·Status: COMPLETED ·Phase: NA
-
Assessment of Optimal Egg Intake in a Healthy Population
NCT02531958 ·Status: COMPLETED ·Phase: NA
-
Egg Diet to Improve Metabolic Health and Function
NCT02760641 ·Status: COMPLETED ·Phase: NA
-
Whole Egg Intake and the Mediterranean Diet
NCT02737293 ·Status: TERMINATED ·Phase: NA
-
Cardioprotective Activities Of Whole Eggs On Vascular Endothelial Function In Prediabetic Adults
NCT02364570 ·Status: COMPLETED ·Phase: NA
-
Egg Effects on the Immunomodulatory Properties of HDL
NCT03577223 ·Status: COMPLETED ·Phase: NA
-
Assessment of TMAO Formation With Egg Intake Versus Choline Supplement in a Healthy Population
NCT03142763 ·Status: COMPLETED ·Phase: NA
-
CABALA Diet & Health Study
NCT03369548 ·Status: UNKNOWN ·Phase: NA
-
Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans
NCT03039023 ·Status: COMPLETED ·Phase: NA
-
Effect of Eggs and Egg Components on Cognitive Performance and Appetite in School-aged Children
NCT03321227 ·Status: COMPLETED ·Phase: NA
-
Meta-analysis of 46 FDA Identified Studies on Lipid Markers
NCT03468127 ·Status: UNKNOWN
-
The Effect of Eggs on Postprandial Metabolism
NCT01351207 ·Status: COMPLETED ·Phase: NA
-
Effect of Diets on the Gut Microbiota Composition and Cardiometabolic Wellbeing
NCT03539666 ·Status: COMPLETED ·Phase: NA
-
Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement.
NCT03877003 ·Status: COMPLETED ·Phase: NA
-
Egg Yolk and Underlying Metabolisms on Modifying HDL Levels in Individuals With Metabolic Syndrome
NCT04608136 ·Status: COMPLETED ·Phase: NA
-
Unravelling the Impact of Diet on Cardiovascular Health in Treated Heterozygous Familial Hypercholesterolemia.
NCT06389825 ·Status: COMPLETED ·Phase: NA
-
Soy Nut Study on Markers of Health
NCT01173380 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
NCT06120400 ·Status: RECRUITING ·Phase: PHASE3
-
Soybean Based Diets and CVD Risk Factors
NCT00175097 ·Status: COMPLETED ·Phase: NA
-
Polymorphisms in CD36 and STAT3 Genes and Different Dietary Interventions Among Patients With Coronary Artery Disease
NCT02202265 ·Status: UNKNOWN ·Phase: NA
-
Replacement of Saturated Fat in Dairy on Total Cholesterol
NCT02089035 ·Status: COMPLETED ·Phase: NA
-
Eggs as Part of a Healthy Breakfast
NCT02297464 ·Status: COMPLETED ·Phase: NA